GLAUCOMA: Edited by Donald L. BudenzAdvances in medical therapy for glaucomaOstler, Erika; Rhee, Douglasa; Burney, Edwarda; Sozeri, Yasemina Author Information aDepartment of Ophthalmology and Visual Sciences and University Hospitals Eye Institute, Case Western Reserve University, Cleveland, Ohio, USA Correspondence to Yasemin Sozeri, MD, Assistant Professor Department of Ophthalmology and Visual Sciences and University Hospitals Eye Institute, Case Western Reserve University, Cleveland, Ohio, USA. Tel: +440 974 4141; e-mail: [email protected] Current Opinion in Ophthalmology: March 2021 - Volume 32 - Issue 2 - p 129-133 doi: 10.1097/ICU.0000000000000740 Buy Metrics Abstract Purpose of review To discuss a new class of medication that has recently become available for the treatment of glaucoma; as well as share insights into developments in glaucoma medicine administration which has the potential to revolutionize medical therapy for glaucoma. Recent findings Newly available eye drops, netarsudil 0.02% and latanoprostene bunod 0.024%, are improving aqueous outflow through the conventional outflow tract. Other new developments in medical glaucoma are focused on alternative methods for sustained glaucoma medication delivery. Summary Newer medications may be able to extend the duration of medically controlled glaucoma, delaying or possibly eliminating the need of glaucoma surgery for some patients. Alternative methods of delivery for glaucoma medications may be a key factor in improving outcomes with currently available medications. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.